Physician's Weekly1 小时
Spesolimab Sustains Skin and QoL Improvements in GPP
The following is a summary of “Effect of spesolimab on sustained disease control in patients with generalized pustular ...
The National2 小时
Two new cancer drugs approved for use in Scotland
In 2024 the SMC accepted several other cancer drugs including dabrafenib, known by the brand name Finlee, for use in combination with trametinib (Spexotras), for treating children aged one and older ...
STV News2 小时
New medicines approved to treat prostate and liver cancers in Scotland
The Scottish Medicines Consortium has approved two new drugs for use with patients via the NHS. Two new medicines have been ...
Two new drugs to treat prostate and liver cancer approved for use in Scotland
TWO new medicines have been approved to help treat prostate and liver cancer patients in Scotland. The Scottish Medicines ...
Dermatology Advisor2 天
Generalized Pustular Psoriasis Flares Are Common With Off-Label Therapies
Patients with generalized pustular psoriasis experienced flares despite the use of traditional off-label therapies and frequently changed treatment.
New analyses on the potential impact of SPEVIGO® in generalized pustular psoriasis patient ...
Boehringer Ingelheim announced new analyses to be presented at the American Academy of Dermatology (AAD) annual meeting in Orlando that explore the effect that SPEVIGO® (spesolimab-sbzo) may have on ...